| ADCETRIS® (brentuximab vedotin) | Adult patients with relapsed or refractory CD30+ Hodgkin lymphoma (HL) |
| Evoltra | Paediatric patients (Acute Lymphoblastic Leukemia) |
| Gazyvaro (obinutuzumab) | Adult patients with Chronic Lymphocytic Leukaemia (CLL) |
| Imnovid® (pomalidomide) | Adult patients with relapsed and refractory multiple myeloma |
| MabCampath | Patients with B-cell chronic lymphocytic leukaemia (B-CLL) |
| Ninlaro | Adult patients with multiple myeloma who have received at least one prior therapy |
| Revlimid® (Lenalidomide) | Adult patients Multiple Myeloma, Myelodysplastic syndromes and Mantle cell lymphoma |
| Soliris | Adults and children with Paroxysmal nocturnal haemoglobinuria (PNH) |
| Zydelig | CLL patients |